Express Scripts, Others Face ERISA Suit Over EpiPen Costs
Pharmacy benefit managers Express Scripts Inc., OptumRx Inc. and Prime Therapeutics LLC have agreed to give Mylan Pharmaceuticals Inc.'s EpiPen favorable placement on drug formularies in exchange for kickbacks, employees under...To view the full article, register now.
Already a subscriber? Click here to view full article